相关实验视频

Updated: Apr 13, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

在GLS1和NAMPT中MYC的依赖性是多发性骨髓瘤的治疗脆弱性

Lama Hasan Bou Issa¹, Léa Fléchon¹, William Laine¹

¹Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.

|March 21, 2024

概括

研究人员确定了谷氨酸酶 (GLS1) 对于MYC驱动的多发性骨髓瘤 (MM) 细胞至关重要. 结合GLS1和NAMPT抑制剂,有望针对这种无法治愈的血液癌症.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

多发性骨髓瘤 (MM) 是一种无法治愈的血液癌症,其中MYC变化驱动恶性瘤.
由于缺乏药物可用性,MYC是一个具有挑战性的治疗目标.
了解MYC的依赖性对于开发新型MM治疗至关重要.

研究的目的:

确定MYC过度表达多发性骨髓瘤细胞所必需的基因和途径.
调查谷氨酸酶 (GLS1) 和NAMPT在MYC驱动的MM中的作用.
评估针对谷氨酸溶解和NAD合成的组合疗法.

主要方法:

使用了大规模的功能丧失屏幕和小分子屏幕.
对同位素模型,CCLE和患者数据集的分析确定了基因依赖.
功能性研究确定了MYC过度表达细胞中的谷氨胺代谢.
评估了GLS1和NAMPT的制药抑制作用.

主要成果:

在MYC过度表达MM细胞中确定了谷氨酸酶 (GLS1) 的依赖性.
发现GLS1对于这些细胞的活力和繁殖至关重要.
药物抑制NAMPT有选择性地影响MYC上调的细胞.
联合GLS1和NAMPT抑制在向MYC驱动的MM方面表现出有效性.

结论:

通过GLS1准谷氨酸分解是MYC驱动的MM的潜在策略.
通过NAMPT抑制NAD合成也会影响MYC驱动的MM细胞.
结合GLS1和NAMPT抑制剂为MYC驱动的多发性骨髓瘤提供了一个有前途的治疗方法.

关键词:

癌症癌症癌症癌症代谢学代谢学代谢学文字转录学 (Transcriptomics) 是一个学科.

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...